Literature DB >> 8253818

Differential induction of nuclear NF-kappa B by protein phosphatase inhibitors in primary and transformed human cells. Requirement for both oxidation and phosphorylation in nuclear translocation.

S D Menon1, S Qin, G R Guy, Y H Tan.   

Abstract

Phosphoseryl/threonyl protein phosphatase inhibitors, viz. okadaic acid and calyculin-A, failed to induce nuclear factor-kappa B (NF-kappa B) nuclear translocation in several primary human cells although a marked and rapid induction was observed in their simian virus 40 transformed counterparts. Inability to induce NF-kappa B cannot be due to a non-activatable system since NF-kappa B was strongly activated by tumor necrosis factor in all the five primary cell types tested. It is also unlikely that the differential induction was due to differential sensitivity of primary and transformed cells to phosphatase inhibitors as the intracellular phosphatase activities of both cell types were equally inhibited by these inhibitors. However, pretreatment with hydrogen peroxide or buthionine sulfoximine, chemicals known to directly or indirectly elevate the intracellular free-radical levels, enabled okadaic acid to induce nuclear translocation of NF-kappa B in primary cells. Conversely cysteine, an antioxidant and precursor of the free radical scavenger, glutathione, inhibited the induction of NF-kappa B by tumor necrosis factor in primary cells, and by okadaic acid or tumor necrosis factor in transformed cells. These data, taken together, suggest that free radical-dependent oxidation and protein phosphorylation are not independent modes of NF-kappa B induction, but are both required for the release of NF-kappa B from I kappa B. Furthermore, the differential induction of NF-kappa B nuclear translocation by okadaic acid in primary and transformed human cells, reported herein, reflects intrinsic differences in the intracellular oxidative state between the two groups of cells. The induction of NF-kappa B by tumor necrosis factor in primary cells suggests that this cytokine fulfills the requirement for oxidation, possibly by inducing the production of free radicals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253818

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Role of ascorbate in the activation of NF-kappaB by tumour necrosis factor-alpha in T-cells.

Authors:  E Muñoz; M V Blázquez; C Ortiz; C Gomez-Díaz; P Navas
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Ambient but not incremental oxidant generation effects intercellular adhesion molecule 1 induction by tumour necrosis factor alpha in endothelium.

Authors:  T Arai; S A Kelly; M L Brengman; M Takano; E H Smith; P J Goldschmidt-Clermont; G B Bulkley
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

3.  Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation.

Authors:  K S Kilgore; E Schmid; T P Shanley; C M Flory; V Maheswari; N L Tramontini; H Cohen; P A Ward; H P Friedl; J S Warren
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

4.  Neurotrophins protect cultured cerebellar granule neurons against the early phase of cell death by a two-component mechanism.

Authors:  M J Courtney; K E Akerman; E T Coffey
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

5.  Thiol regulation of endotoxin-induced release of tumour necrosis factor alpha from isolated rat Kupffer cells.

Authors:  B A Neuschwander-Tetri; J M Bellezzo; R S Britton; B R Bacon; E S Fox
Journal:  Biochem J       Date:  1996-12-15       Impact factor: 3.857

6.  Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination.

Authors:  D C Scherer; J A Brockman; Z Chen; T Maniatis; D W Ballard
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  The protein phosphatase inhibitor calyculin A stimulates chemokine production by human synovial cells.

Authors:  N J Jordan; M L Watson; J Westwick
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

8.  Inhibition of the differentiation of human myeloid cell lines by redox changes induced through glutathione depletion.

Authors:  F Esposito; V Agosti; G Morrone; F Morra; C Cuomo; T Russo; S Venuta; F Cimino
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

9.  Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli.

Authors:  E B Traenckner; H L Pahl; T Henkel; K N Schmidt; S Wilk; P A Baeuerle
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

10.  A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B.

Authors:  E B Traenckner; S Wilk; P A Baeuerle
Journal:  EMBO J       Date:  1994-11-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.